Document Detail

Effect of low intravaginal doses of prostaglandin E2 on the closure time of the ductus arteriosus in term newborn infants.
MedLine Citation:
PMID:  8463916     Owner:  NLM     Status:  MEDLINE    
Seventeen term newborn infants (control subjects) and 17 whose mothers had been given intravaginal doses of prostaglandin E2 (PGE2) were examined serially by color Doppler echocardiography to determine whether maternal PGE2 prolonged ductal patency. No clinically relevant differences in closure times were found. Low-dose intravaginal PGE2 therapy was not associated with prolonged ductal patency in term infants.
D A Danford; W F Rayburn; A M Miller; G L Felix; M E Bussey
Related Documents :
19902266 - Ibuprofen in very preterm infants impairs renal function for the first month of life.
12887066 - Cardiac catheterisation in infants weighing less than 2500 grams.
641216 - Indomethacin disposition and indomethacin-induced platelet dysfunction in premature inf...
11054226 - Defining the role of extended saphenofemoral junction ligation: a prospective comparati...
9923486 - Decreased prevalence of retinopathy of prematurity in an inner-city hospital.
10972036 - Colonization and transmission of ureaplasma urealyticum and mycoplasma hominis from mot...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of pediatrics     Volume:  122     ISSN:  0022-3476     ISO Abbreviation:  J. Pediatr.     Publication Date:  1993 Apr 
Date Detail:
Created Date:  1993-04-30     Completed Date:  1993-04-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  632-4     Citation Subset:  AIM; IM    
Department of Pediatrics, University of Nebraska College of Medicine, Omaha.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Intravaginal
Dinoprostone* / administration & dosage,  pharmacology
Ductus Arteriosus / drug effects*,  physiology,  ultrasonography
Echocardiography, Doppler
Infant, Newborn
Time Factors
Reg. No./Substance:
0/Oxytocics; 363-24-6/Dinoprostone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemia of pre...
Next Document:  Nephrocalcinosis in very low birth weight neonates: family history of kidney stones and ethnicity as...